Compare Aventis Pharma with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DISHMAN PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DISHMAN PHARMA SANOFI INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 34.7 25.1 138.3% View Chart
P/BV x 6.1 3.3 181.6% View Chart
Dividend Yield % 1.4 0.7 215.9%  

Financials

 SANOFI INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
DISHMAN PHARMA
Mar-16
SANOFI INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,840374 1,826.9%   
Low Rs4,630129 3,591.9%   
Sales per share (Unadj.) Rs1,203.1197.8 608.3%  
Earnings per share (Unadj.) Rs165.321.2 779.3%  
Cash flow per share (Unadj.) Rs209.934.7 604.4%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.8 184.3%  
Book value per share (Unadj.) Rs963.6179.9 535.7%  
Shares outstanding (eoy) m23.0380.69 28.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.3 374.7%   
Avg P/E ratio x34.711.9 292.4%  
P/CF ratio (eoy) x27.37.2 377.1%  
Price / Book Value ratio x6.01.4 425.5%  
Dividend payout %50.89.4 538.9%   
Avg Mkt Cap Rs m132,07820,306 650.5%   
No. of employees `0003.30.8 398.2%   
Total wages/salary Rs m4,0685,355 76.0%   
Avg. sales/employee Rs Th8,393.819,252.7 43.6%   
Avg. wages/employee Rs Th1,232.46,459.5 19.1%   
Avg. net profit/employee Rs Th1,153.02,064.1 55.9%   
INCOME DATA
Net Sales Rs m27,70815,961 173.6%  
Other income Rs m897265 338.0%   
Total revenues Rs m28,60516,226 176.3%   
Gross profit Rs m6,2354,103 152.0%  
Depreciation Rs m1,0271,091 94.2%   
Interest Rs m7944 0.7%   
Profit before tax Rs m6,0982,334 261.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292624 367.5%   
Profit after tax Rs m3,8061,711 222.4%  
Gross profit margin %22.525.7 87.5%  
Effective tax rate %37.626.7 140.7%   
Net profit margin %13.710.7 128.1%  
BALANCE SHEET DATA
Current assets Rs m15,92211,018 144.5%   
Current liabilities Rs m6,2359,517 65.5%   
Net working cap to sales %35.09.4 371.8%  
Current ratio x2.61.2 220.6%  
Inventory Days Days64110 57.6%  
Debtors Days Days2135 59.9%  
Net fixed assets Rs m7,53916,304 46.2%   
Share capital Rs m230161 142.5%   
"Free" reserves Rs m21,96212,907 170.2%   
Net worth Rs m22,19214,516 152.9%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m29,83929,805 100.1%  
Interest coverage x872.13.5 25,126.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.90.5 173.4%   
Return on assets %12.88.9 143.4%  
Return on equity %17.211.8 145.5%  
Return on capital %27.517.5 156.9%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m7,5874,952 153.2%   
Fx outflow Rs m7,145697 1,025.4%   
Net fx Rs m4424,255 10.4%   
CASH FLOW
From Operations Rs m3,7392,786 134.2%  
From Investments Rs m-731-1,529 47.8%  
From Financial Activity Rs m-1,972-941 209.5%  
Net Cashflow Rs m1,036316 327.4%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 3.7 389.2%  
FIIs % 14.6 12.7 115.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 22.1 47.5%  
Shareholders   15,184 46,261 32.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  VENUS REMEDIES  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Over 100 Points Down; Banking and IT Stocks Under Pressure(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.9% while the Hang Seng is also down 0.9%.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Sep 17, 2019 10:01 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS